Burk Oliver, Arnold Katja A, Geick Anke, Tegude Heike, Eichelbaum Michel
Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Auerbachstrasse 112, D-70376 Stuttgart, Germany.
Biol Chem. 2005 Jun;386(6):503-13. doi: 10.1515/BC.2005.060.
MDR1/P-glycoprotein is an efflux transporter determining the absorption and presystemic elimination of many xenobiotics in the gut. Thus, interindividual differences in MDR1 expression may affect the efficacy of drug treatment. The expression of MDR1 is partially controlled by the pregnane X receptor (PXR), which mediates induction by many xenobiotics. Since it has been described that the nuclear receptors PXR and constitutive androstane receptor (CAR) can bind to the same binding sites, we investigated the role of CAR in the regulation of MDR1 gene expression. We demonstrate here by gel shift and transfection experiments that CAR binds to distinct nuclear receptor response elements in the -7.8 kbp enhancer of MDR1 and transactivates MDR1 expression through DR4 motifs to which the receptor binds as a heterodimer with RXR or as a monomer, respectively. Expression of the endogenous MDR1 gene is elevated in cells stably expressing CAR, thus arguing for the functional relevance of CAR-dependent activation of MDR1 . The physiological relevance of the regulation of MDR1 by CAR is further suggested by correlation of the expression of CAR and MDR1 in the human small intestine. In summary, our data suggest that CAR plays a role in the regulation of intestinal MDR1 expression.
多药耐药蛋白1/ P-糖蛋白是一种外排转运蛋白,决定了许多外源性物质在肠道中的吸收和首过消除。因此,多药耐药蛋白1表达的个体差异可能会影响药物治疗的效果。多药耐药蛋白1的表达部分受孕烷X受体(PXR)控制,PXR介导许多外源性物质的诱导作用。由于已有报道称核受体PXR和组成型雄烷受体(CAR)可结合相同的结合位点,我们研究了CAR在多药耐药蛋白1基因表达调控中的作用。我们通过凝胶迁移和转染实验证明,CAR与多药耐药蛋白1基因-7.8 kbp增强子中不同的核受体反应元件结合,并通过DR4基序反式激活多药耐药蛋白1的表达,该受体分别作为与维甲酸X受体(RXR)的异二聚体或单体与DR4基序结合。在稳定表达CAR的细胞中,内源性多药耐药蛋白1基因的表达升高,这表明CAR依赖性激活多药耐药蛋白1具有功能相关性。人小肠中CAR和多药耐药蛋白1表达的相关性进一步提示了CAR对多药耐药蛋白1调控的生理相关性。总之,我们的数据表明CAR在肠道多药耐药蛋白1表达的调控中发挥作用。